Detalhe da pesquisa
1.
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study).
EClinicalMedicine;
63: 102160, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37649806
2.
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Int J Infect Dis;
126: 164-173, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36403819
3.
An enzyme immunoassay to determine human chorionic gonadotropin (HCG) in serum and urine samples using an ultra-microanalytical system.
J Pharm Biomed Anal;
204: 114239, 2021 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34252818